海尔生物
(688139)
| 流通市值：105.65亿 | | | 总市值：105.65亿 |
| 流通股本：3.16亿 | | | 总股本：3.16亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,963,966,298.13 | 1,296,472,460.72 | 652,078,594.24 | 2,328,672,376.01 |
| 营业总成本 | 1,769,770,351.94 | 1,168,979,905.85 | 581,544,373.93 | 2,111,350,181.83 |
| 其他经营收益 | | | | |
| 营业利润 | 235,601,634.54 | 155,092,649.78 | 83,932,443.64 | 266,343,393.47 |
| 利润总额 | 237,648,196.29 | 156,464,435.86 | 84,606,427.65 | 264,759,972.83 |
| 净利润 | 226,129,246.2 | 148,915,536.8 | 79,989,325.33 | 255,132,280.57 |
| 每股收益 | | | | |
| 其他综合收益 | -4,601,274.6 | -4,460,748.4 | -9,068.24 | 10,148,619.24 |
| 综合收益总额 | 221,527,971.6 | 144,454,788.4 | 79,980,257.09 | 265,280,899.81 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,954,087,827.51 | 2,805,715,189.2 | 2,741,389,939.31 | 2,658,841,758.77 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,000,764,882.63 | 3,020,997,990.96 | 3,114,317,348.35 | 3,132,673,130.46 |
| 资产总计 | 5,954,852,710.14 | 5,826,713,180.16 | 5,855,707,287.66 | 5,791,514,889.23 |
| 流动负债: | | | | |
| 流动负债合计 | 1,061,871,904.13 | 1,054,754,199.57 | 1,068,487,603.69 | 1,085,490,263.29 |
| 非流动负债: | | | | |
| 非流动负债合计 | 104,313,287.05 | 102,576,751.28 | 85,145,145.73 | 82,829,809.84 |
| 负债合计 | 1,166,185,191.18 | 1,157,330,950.85 | 1,153,632,749.42 | 1,168,320,073.13 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,504,422,812.36 | 4,421,421,549.27 | 4,454,048,303.09 | 4,375,697,060.09 |
| 股东权益合计 | 4,788,667,518.96 | 4,669,382,229.31 | 4,702,074,538.24 | 4,623,194,816.1 |
| 负债和股东权益合计 | 5,954,852,710.14 | 5,826,713,180.16 | 5,855,707,287.66 | 5,791,514,889.23 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,961,763,979.54 | 1,296,423,314.09 | 601,271,685.33 | 2,537,076,116.52 |
| 经营活动现金流出小计 | 1,775,387,536.84 | 1,152,147,743.36 | 589,594,457.98 | 2,269,181,743.34 |
| 经营活动产生的现金流量净额 | 186,376,442.7 | 144,275,570.73 | 11,677,227.35 | 267,894,373.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,265,187,953.71 | 1,972,303,693.31 | 785,218,638.16 | 3,978,287,060.95 |
| 投资活动现金流出小计 | 3,234,481,972.17 | 1,831,534,319.12 | 541,678,197.98 | 3,961,541,956.24 |
| 投资活动产生的现金流量净额 | 30,705,981.54 | 140,769,374.19 | 243,540,440.18 | 16,745,104.71 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 84,991,201.76 | 13,731,201.76 | 5,000,000 | 738,191,461.12 |
| 筹资活动现金流出小计 | 164,670,982.35 | 119,456,489.39 | 6,633,468.06 | 1,006,927,877.65 |
| 筹资活动产生的现金流量净额 | -79,679,780.59 | -105,725,287.63 | -1,633,468.06 | -268,736,416.53 |
| 汇率变动对现金及现金等价物的影响 | -10,504,104.59 | -8,907,018.78 | -7,434,796.11 | 3,199,531.7 |
| 现金及现金等价物净增加额 | 126,898,539.06 | 170,412,638.51 | 246,149,403.36 | 19,102,593.06 |
| 期末现金及现金等价物余额 | 680,705,162.8 | 724,219,262.25 | 799,956,027.1 | 553,806,623.74 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 170,412,638.51 | - | 19,102,593.06 |
最新报告期：2026-10-25| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西南证券 | 杜向阳 | 0.91 | 1.05 | 1.20 | 2026-10-25 |
| 中信建投 | 朱红亮,王在存,贺菊颖 | 0.92 | 1.07 | 1.24 | 2026-09-30 |
| 华创证券 | 郑辰,李婵娟,陈俊威 | 0.91 | 1.04 | 1.20 | 2026-09-26 |
| 东海证券 | 杜永宏 | 0.91 | 1.01 | 1.17 | 2026-09-15 |
| 中国银河 | 孟熙,程培 | 0.91 | 1.04 | 1.18 | 2026-08-22 |